DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Disopyramide

Disopyramide

  • Table 2. 2012 AGS Beers Criteria for Potentially

    Table 2. 2012 AGS Beers Criteria for Potentially

  • Label (PDF)

    Label (PDF)

  • NORPACE- Disopyramide Phosphate Capsule, Gelatin Coated

    NORPACE- Disopyramide Phosphate Capsule, Gelatin Coated

  • Disopyramide for Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Medical Therapy Approxima

    Disopyramide for Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Medical Therapy Approxima

  • Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes

    Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes

  • DISOPYRAMIDE PHOSPHATE CAPSULES, Usp31273129rx Only

    DISOPYRAMIDE PHOSPHATE CAPSULES, Usp31273129rx Only

  • DOMASYS Standard

    DOMASYS Standard

  • Antiarrhythmic Pharmacotherapy

    Antiarrhythmic Pharmacotherapy

  • Some Cardiovascular Problems with Disopyramide JOHN HAMER

    Some Cardiovascular Problems with Disopyramide JOHN HAMER

  • Ocular Side Effects of Disopyramide

    Ocular Side Effects of Disopyramide

  • Disopyramide (Norpace)

    Disopyramide (Norpace)

  • Emerging Medical Treatment for Hypertrophic Cardiomyopathy

    Emerging Medical Treatment for Hypertrophic Cardiomyopathy

  • Pharmacokinetic Interactions Between Digoxin and Other Drugs

    Pharmacokinetic Interactions Between Digoxin and Other Drugs

  • A High-Performance Liquid Chromatography Assay Method for the Determination of Lidocaine in Human Serum

    A High-Performance Liquid Chromatography Assay Method for the Determination of Lidocaine in Human Serum

  • Blockade of Cardiac Sodium Channels. Competition Between the Permeant Ion and Antiarrhythmic Drugs

    Blockade of Cardiac Sodium Channels. Competition Between the Permeant Ion and Antiarrhythmic Drugs

  • Effects of Disopyramide and Mexiletine on the Terminal Repolarization Process of the in Situ Heart Assessed Using the Halothane-Anesthetized in Vivo Canine Model

    Effects of Disopyramide and Mexiletine on the Terminal Repolarization Process of the in Situ Heart Assessed Using the Halothane-Anesthetized in Vivo Canine Model

  • Ketoconazole) Tablets

    Ketoconazole) Tablets

  • In Vitro to in Vivo Extrapolation for Drug-Induced Liver Injury Using a Pair Ranking Method

    In Vitro to in Vivo Extrapolation for Drug-Induced Liver Injury Using a Pair Ranking Method

Top View
  • Electrophysiologic Effects of Sodium Channel Blockade on Anisotropic
  • Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk
  • Verapamil Hydrochloride Injection, USP for Intravenous Injection Protect from Light
  • Verapamil Hydrochloride Injection, USP Prescribing Information
  • Mexiletine Hydrochloride Capsules USP Rx Only
  • Disopyramide
  • Anti Arrhythmic Drugs A/Prof Andrew Dean
  • Drug Class Review on Calcium Channel Blockers
  • The Effect of Phenytoin on the Disposition of Disopyramide in Normal Volunteers
  • Disopyramide Phosphate Available Forms Indications & Dosages
  • VPC) Irrespective of the Relationship Between the VPC and the Underlying Heart Rate
  • Rythmodan (Disopyramide)
  • Interactions with PBC Agents
  • Tachycardia with Mexiletine and Disopyramide Control by Programmed Ventricular Stimulation
  • Recommendations for Prescription of Oral Anti-Inflammatory Agents in Oral Surgery in Adults
  • Disopyramide: Pediatric Medication | Memorial Sloan Kettering Cancer Center
  • Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block
  • IA Hotline0112sodium Channel


© 2024 Docslib.org    Feedback